DL Methionine Production Cost Reports

DL-Methionine production cost report provides a comprehensive analysis and know-how for setting up a DL-Methionine production plant. The study covers all the requisite aspects that one needs to know for the production of DL-Methionine. This includes manufacturing processes, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.

Methionine is an amino acid that contains sulfur and butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4. It plays the role of an Escherichia coli metabolite, a plant metabolite, a Saccharomyces cerevisiae metabolite, an algal metabolite, and a Daphnia magna metabolite. DL-Methionine is the preparation of methionine, including a mix of D-methionine and L-methionine isomers. It is an essential amino acid which is protein's building block.

DL-methionine, with the chemical formula C5H11NO2S and a molecular weight of 149.21 g/mol, is a white crystalline chemical powder. It has a faint smell. It can be made using propylene aldehyde via the reaction of acrolein and methanethiol, extraction method and an industrial preparation method. Its density is 1.206 g/cm3. Its respective melting and boiling points are 270-273 °C and 306.9 °C. Also, its flash point is 139.4 °C. It is water soluble (solubility of 2.9 g/100 mL (20 °C)).

DL-methionine demand is being driven by its importance of it as an essential amino acid in the dog's overall growth and development. It is a vital ingredient added to commercial pet treats, foods, and products. It also plays a role in acidifying the urine in dogs and helps address bladder infections, reducing the risk of kidney and bladder stones, the amount of nitrogen, and strong, unpleasant urine odours. Aside from that, it also helps prevent various diseases by acting as an antioxidant. Other uses of the chemical substance include as a feed additive, in pharmaceuticals and in pet food products, thereby furthering the market expansion.